Weather Alert: A major winter storm is likely to impact the Philadelphia region this weekend into Monday. Temple Health remains open, though some appointments or services may be adjusted. Patients will be contacted directly if their visit is affected. Please check Foxchase.org for updates and monitor myTempleHealth for changes to scheduled appointments.
Harbour BioMed
Shanghai, China
Harbour BioMed and Fox Chase Cancer Center initiated discussions related to opening clinical trials at Fox Chase using Harbour BioMed’s candidate oncology agents. Harbour BioMed is a global, clinical stage biopharmaceutical company developing innovative therapeutics in the fields of immuno-oncology and inflammatory diseases. Harbour BioMed’s current portfolio includes four clinical-stage in-licensed compounds and a rapidly emerging set of therapeutics coming from its internal discovery efforts as well as co-discovery/development collaborations with academic institutions and biopharmaceutical companies.
About Our Agreement
Confidentiality Agreement - details are confidential and cannot be disclosed to the public.
